Crossmark

Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model

Crossref DOI link: https://doi.org/10.1186/s40360-018-0232-3

Published Online: 2018-07-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fukuyama, Tomoki

Ehling, Sarah

Wilzopolski, Jenny

Bäumer, Wolfgang http://orcid.org/0000-0002-4346-5911
Funding

Funding for this research was provided by:

Realm Therapeutics
License Information

Text and Data Mining valid from 2018-07-03
More Information

Article History

Received: 9 February 2018

Accepted: 25 June 2018

First Online: 3 July 2018

Competing interests

: The authors declare that they have no competing interests.

: The study was conducted according to the national guidelines for the Care and Use of Laboratory Animals. All protocols described herein have been approved by the Animal Care and Use Committee of the North Carolina State University (IACUC Protocol No. 13–111-B).

: Not applicable.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.